IPO/FPO Analysis
IPO and FPO reviews — what the numbers say before you subscribe.
132 articles
-
Heranba Industries IPO Review: Avoid, Intense Working Capital Requirement
To meet business working capital requirements. To meet general corporate purposes. To meet public issue expenses.
-
RailTel IPO Review: Avoid, Not a wealth creator
Offer for Sale by existing shareholders.
-
Nureca Limited IPO Review: Avoid
Incorporated in 2016, Nureca Limited is a healthcare and wellness products distributor.
-
Brookfield India REIT IPO Review; Avoid
Partial/ full payment of debts of the Asset SPVs. Meeting general corporate purposes.
-
Stove Kraft Limited IPO Review: Avoid, Not a proven business model yet
Incorporated on June 28, 1999, Stove Kraft is Rs. 700 Cr, kitchen solutions and an emerging home solutions brand.
-
Home First Finance Company IPO Review: Subscribe, Low Ticket size lending
Fresh Issue (Rs 268 Cr) to be utilized for augmenting equity capital base for meeting future growth requirements.
-
IPO Historic Table 2021
If you liked what you read and would like to put it in to practice Register at MoneyWorks4me.com.
-
Indigo Paints IPO Review – Subscribe, A fast grower in market’s favourite industry
Indigo Paints, one of the fastest-growing paint companies in India (in terms of volume growth), is the 5th largest company in the decorative paint industry.
-
IRFC IPO Review: Limited upside despite high growth
Fresh Issue (Rs 1,500 Cr) to be utilized for augmenting equity capital base for meeting future growth requirements and general corporate purposes.
-
Mrs. Bectors Food IPO Review: Subscribe only for Listing gains, Wait for sustainable Growth
Mrs. Bectors Food Specialities Limited (Bectors Food) was established in 1995 as a joint venture (JV) with Quaker Oats for supplying condiments such ketchup and sauces to McDonald’s and gradually added buns,…
-
Burger King India Ltd IPO Review: Potential of becoming a compounder
Burger King India Limited, a ~$100 million QSR (quick-service restaurant) chain, is an Indian subsidiary of US-based Restaurant Brands International Inc. via holding company ‘QSR Asia’.
-
Gland Pharma IPO Review: Large contract manufacturer for injectables
Offer for sale by existing shareholders (~5000 Cr) and for working capital (1250 Cr).
